CurrentCardio coverage · page 3 of 3

JACC: CardioOncology

Briefs 81–113 of 113 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: CardioOncology

All coverage, newest first

JACC CardioOncol2 May 2023
Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning
Randomised controlled trial
JACC CardioOncol2 May 2023
Endothelin Receptor Blocker Reverses Breast Cancer–Induced Cardiac Remodeling
Mechanistic studyCardio-oncology & other
JACC CardioOncol18 Apr 2023
Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients
Cohort study
JACC CardioOncol18 Apr 2023
Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer
Cohort study
JACC CardioOncol11 Apr 2023
Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population
Cohort studyCardio-oncology & other
JACC CardioOncol11 Apr 2023
Risk of Cancer After Diagnosis of Cardiovascular Disease
Cohort studyCardio-oncology & other
JACC CardioOncol28 Mar 2023
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials
Meta-analysis
JACC CardioOncol21 Mar 2023
Remote Ischemic Conditioning in Pediatric Cancer Patients Receiving Anthracycline Chemotherapy: A Sham-Controlled Single-Blind Randomized Trial
Randomised controlled trial
JACC CardioOncol21 Mar 2023
Physical Activity During Breast Cancer Therapy Associates With Preserved Exercise Capacity and Cardiac Function (WF97415)
Cohort studyCardio-oncology & other
JACC CardioOncol21 Mar 2023
Prevalence of Diastolic Dysfunction in Adult Survivors of Childhood Cancer: A Report From SJLIFE Cohort
Cohort study
JACC CardioOncol7 Feb 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
Case-control study
JACC CardioOncol7 Feb 2023
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
Cohort study
JACC CardioOncol17 Jan 2023
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer
Cohort study
JACC CardioOncolDate not resolved
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants
Diagnostic or prognostic studyPulmonary vascular & VTE
JACC CardioOncolDate not resolved
A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis
Meta-analysisCardiometabolic & kidney
JACC CardioOncolDate not resolved
Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma: Incidence, Predictors, and Prognostic Impact
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 Patients
Cohort studyHeart failure
JACC CardioOncolDate not resolved
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy
Randomised controlled trialCardio-oncology & other
JACC CardioOncolDate not resolved
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis
Secondary analysisHeart failure
JACC CardioOncolDate not resolved
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review
Research articleHeart failure
JACC CardioOncolDate not resolved
Effects of Aerobic Exercise on Cardiorespiratory Fitness and Cardiovascular Risk Factors in Long-Term Breast Cancer Survivors: A Randomized Controlled Trial
Randomised controlled trialCardio-oncology & other
JACC CardioOncolDate not resolved
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art Review
Research articleCardio-oncology & other
JACC CardioOncolDate not resolved
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor–Related Myocarditis
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Longitudinal Patterns of Cardiovascular Disease and Cancer Mortality in Renal Cell Carcinoma Patients by Tumor Stage
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent Toxicity
Research articleCardio-oncology & other
JACC CardioOncolDate not resolved
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Polygenic Risk for Cardiometabolic and Cardiovascular Disease in a Multiethnic Cohort of Breast Cancer Survivors
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Following Hematopoietic Stem Cell Transplantation
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort Study
Cohort studyCardio-oncology & other
JACC CardioOncolDate not resolved
Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis
Cohort studyHeart failure
JACC CardioOncolDate not resolved
Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site
Cohort studyPulmonary vascular & VTE

All 113 Briefs in ExploreShowing Briefs 81–113 of 113, newest first